Tretinoin Gel
Dermatology
PreclinicalActive
Key Facts
About Avecho Biotechnology
Australiancho leverages a vitamin‑E‑based delivery platform to boost efficacy and tolerability of diverse health products.
View full company profileTherapeutic Areas
Other Dermatology Drugs
| Drug | Company | Phase |
|---|---|---|
| Not specified in provided content | 3Sbio | Various |
| Dermatology Candidates | Aucta Pharmaceuticals | Not Specified |
| PCI for Nucleic Acid Delivery | PCI Biotech | Preclinical |
| Undisclosed Transcription Factor Program | Montai Therapeutics | Development Candidate (DC) expected 2026 |
| Undisclosed Biologic Replacement Program | Montai Therapeutics | Development Candidate (DC) expected 2027 |